March 20, 2018 — Febuxostat, a gout ...
Pharmaceuticals
This channel includes news and new technology innovations for cardiovascular pharmaceutics. This includes antiplatelet agents, anticoagulation drugs, INR testing, NOAC, OAC, IV administered drugs such as Heprin, and dual antiplatelet therapy.
March 20, 2018 — The anti-inflammatory...
March 20, 2018 — Treatment with the blood-thinning drug dabigatran significantly reduced the risk of death, heart...
March 20, 2018 — Getting a large dose of a statin did not have an impact on major adverse cardiac events among a...
March 20, 2018 — Among people younger than 75 years who were given clot busters to treat a heart attack, taking the...
March 20, 2018 — When patients who had a heart attack were given vouchers to cover their co-payments for...
March 20, 2018 — Patients with acute coronary syndrome experienced a substantially lower rate of heart attack,...
March 20, 2018 — A pill combining low doses of three...
March 20, 2018 — African-American men who received medical intervention aimed at controlling their...
March 19, 2018 — The combined rate of death from any cause, heart attack or stroke within 18 months was not...
March 15, 2018 — For people living with both Type 2 diabetes and heart failure, taking an...
March 14, 2018 — A late-breaking analysis of the landmark COMPASS study presented at the American College of...
March 14, 2018 — After six months of follow-up, women newly diagnosed with...
March 14, 2018 — Breast cancer...
March 13, 2018 – Among patients with persistently high cholesterol despite high-intensity statin therapy, the...